After negative results and serious side effects as shown in the study called, HPS2  TRIVE,  Merck, the makers of anti cholesterol pill TREDAPTIVE, has announced to stop selling and marketing the drug. Merck has announced that the study, Heart Protection Study 2- Treatment of HDL to Reduce the Incidence of Vascular Events, which uses Tredaptive does not meet its […]